$91.12
+1.26 (+1.40%)
At Close: Jun 03, 2026
IRadimed (IRMD) Q1 Earnings and Revenues Top Estimates
12:25pm, Friday, 29'th Apr 2022 Zacks Investment Research
iRadimed (IRMD) delivered earnings and revenue surprises of 4.76% and 0.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
11:00am, Friday, 29'th Apr 2022 GlobeNewswire Inc.
WINTER SPRINGS, Fla., April 29, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three months ended March 31, 2022. The
IRadimed (IRMD) Q1 Earnings and Revenues Top Estimates
09:47am, Friday, 29'th Apr 2022
iRadimed (IRMD) delivered earnings and revenue surprises of 4.76% and 0.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th
11:00am, Tuesday, 05'th Apr 2022 GlobeNewswire Inc.
WINTER SPRINGS, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market
IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th
07:00am, Tuesday, 05'th Apr 2022
WINTER SPRINGS, Fla., April 05, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market op
Is Indivior PLC (INVVY) Stock Outpacing Its Medical Peers This Year?
01:40pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Here is how Indivior PLC (INVVY) and iRadimed (IRMD) have performed compared to their sector so far this year.
Here's Why Momentum in iRadimed (IRMD) Should Keep going
12:50pm, Friday, 18'th Mar 2022 Zacks Investment Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Here's Why Momentum in iRadimed (IRMD) Should Keep going
10:32am, Friday, 18'th Mar 2022
If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Is iRadimed (IRMD) Outperforming Other Medical Stocks This Year?
02:40pm, Tuesday, 08'th Mar 2022 Zacks Investment Research
Here is how iRadimed (IRMD) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
Is iRadimed (IRMD) Outperforming Other Medical Stocks This Year?
11:17am, Tuesday, 08'th Mar 2022
Here is how iRadimed (IRMD) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
Here's Why Momentum in iRadimed (IRMD) Should Keep going
01:50pm, Wednesday, 02'nd Mar 2022 Zacks Investment Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price
Here's Why Momentum in iRadimed (IRMD) Should Keep going
09:57am, Wednesday, 02'nd Mar 2022
If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price
iRadimed (IRMD) is an Incredible Growth Stock: 3 Reasons Why
05:45pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
iRadimed (IRMD) is an Incredible Growth Stock: 3 Reasons Why
01:52pm, Wednesday, 23'rd Feb 2022
iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is iRadimed (IRMD) Outperforming Other Medical Stocks This Year?
02:40pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Here is how iRadimed (IRMD) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.
Sign In
Buy IRMD